General Dermatology

Energy and protein drinks may exacerbate acne through high sugar and insulin levels, impacting skin health among athletes and students.

What were the top dermatology hits of 2025?

Explore the risks of bypassing dermatologists for DIY skin care and telehealth treatments, highlighting real patient experiences and expert insights.

This review of the latest dermatologic studies includes case studies on allergic contact dermatitis from UV nail polish, the introduction of the visual aesthetics methodology, a review of topical timolol, and more.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about the first commercial treatment of Zevaskyn for RDEB, the global prevalence of HS, a new STAT6 degrader for AD, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

John Barbieri, MD, MBA, discusses how deteriorating prior authorization processes are compromising access to essential dermatologic therapies.

Galderma initiates a pivotal study on nemolizumab, targeting Chronic Pruritus of Unknown Origin, aiming to provide relief for this challenging condition.

Explore the emerging concept of PDE4 inhibitor-responsive dermatoses, offering innovative nonsteroidal treatments for chronic inflammatory skin conditions.

Discover how the SkinCARE Questionnaire can measure the emotional impact of everyday skin health, enhancing understanding of skin-related wellbeing in healthy individuals.

FDA proposes adding bemotrizinol to sunscreen ingredients, enhancing UV regulations and protection options for consumers for the first time since 1999.

This review of the latest dermatologic studies includes a review on JAK-induced acne, a case series of atypical pediatric-onset Behçet's Disease, research on drug survival in AD, and more.

Dermatology Times highlights 2025's innovations in dermatology, featuring new therapies, expert insights, and a look ahead to 2026 advancements.

John Barbieri, MD, MBA, outlines how missing reviewer identification, unclear step-therapy requirements, and limited engagement during appeals contribute to delays, inefficiencies, and potential clinical harm for patients.

PolarityBio advances SkinTE for diabetic foot ulcers, aiming for a breakthrough in chronic wound treatment with promising trial results announced soon.

Discover how hotel shampoos, conditioners, and body washes contribute to allergic contact dermatitis, revealing significant regional differences in allergen prevalence.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about clascoterone 5% for hair growth improvements, dermatology's role in lung cancer toxicities, IPV in female psoriasis patients, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Selected pieces will be featured in Dermatology Times’ year-end and early-2026 coverage.

Discover how a proprietary extract from saw palmetto promotes hair growth and reduces thinning in adults, offering a safe alternative to traditional treatments.